Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$38,905,914
+$2,741,478 QoQ
Shares Held
32,437
-17.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#615
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Impax Asset Management Group plc holds $150,919,898 across 7 Drug Manufacturers - General names. LLY ranks #1 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
32,437 | $38,905,914 | |
| 2 | JNJ |
Johnson & Johnson
|
134,357 | $34,122,647 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
224,260 | $28,333,008 | |
| 4 | MRK |
Merck & Co., Inc.
|
204,194 | $26,238,929 | |
| 5 | ABBV |
AbbVie Inc.
|
43,138 | $10,855,246 | |
| 6 | AMGN |
Amgen Inc
|
18,289 | $6,622,812 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
101,377 | $5,841,342 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,905,914 | 32,437 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $36,164,436 | 39,319 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $49,146,195 | 45,731 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $45,268,027 | 59,329 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $53,975,436 | 69,241 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $50,742,258 | 61,438 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $35,945,864 | 46,562 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $18,954,686 | 21,395 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $19,883,050 | 21,961 | Shares | Defined | 2024-11-08 | |
| 2024-03-31 | $21,695,748 | 27,888 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $17,643,822 | 30,268 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $15,419,928 | 28,708 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $14,486,323 | 30,889 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $10,580,770 | 30,810 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $11,773,828 | 32,183 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $11,728,551 | 36,272 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $12,200,126 | 37,628 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $10,940,193 | 38,203 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,996,870 | 39,812 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,536,588 | 41,275 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,456,224 | 41,200 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $7,697,731 | 41,204 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,409,256 | 26,115 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,073,385 | 34,275 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,791,080 | 23,091 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,133,962 | 22,592 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||